Silicon nanocrystals(SiNCs)have great potential to become environmental friendly alternatives to heavy-metal containing nanocrystals for applications including medical imaging,lighting and *** exhibit excellent photos...
详细信息
Silicon nanocrystals(SiNCs)have great potential to become environmental friendly alternatives to heavy-metal containing nanocrystals for applications including medical imaging,lighting and *** exhibit excellent photostability,non-toxicity and abundant resources,but their often reported inefficient and spectrally limited light emission seriously impair their *** we demonstrate a new method that converts SiNCs into an efficient and robust multi-chromatic ***~15 keV electron-beam irradiation of oxide-capped SiNCs,we introduce several types of color centers into the nanocrystal’s oxide shell with efficient blue,green and red emission bands,together yielding warm-white photoluminescence,even for a single *** centers are not native to the original system and we relate them to known defects in *** in the silica host,however,here the centers are efficiently optically *** further optimization and up-scaling of this method,e-beam irradiated SiNCs can be of great interest as white phosphors for applications such as LEDs.
BACKGROUND Individuals with Lynch syndrome(LS)and hereditary non-polyposis colorectal cancer(HNPCC)are at increased risk of both colorectal cancer and other *** interplay between immunosuppression,a comorbid inflammat...
详细信息
BACKGROUND Individuals with Lynch syndrome(LS)and hereditary non-polyposis colorectal cancer(HNPCC)are at increased risk of both colorectal cancer and other *** interplay between immunosuppression,a comorbid inflammatory condition(CID),and HNPCC on cancer risk is *** To evaluate the impact of CIDs,and exposure to monoclonal antibodies and immunomodulators,on cancer risk in individuals with *** Individuals prospectively followed in a hereditary cancer registry with LS/HNPCC with the diagnosis of inflammatory bowel disease or rheumatic disease were *** compared the proportion of patients with cancer in LS/HNPCC group with and without a *** also compared the proportion of patients who developed cancer following a CID diagnosis based upon exposure to immunosuppressive *** A total of 21 patients with LS/HNPCC and a CID were compared to 43 patients with LS/HNPCC but no *** occurred in 84.2% with a CID compared to 76.7% without a CID(P=0.74)with no difference in age at first cancer diagnosis 45.5±14.6 vs 43.8±7.1 years(P=0.67).LS specific cancers were diagnosed in 52.4% with a CID vs 44.2% without a CID(P=0.54).Nine of 21(42.9%)patients were exposed to biologics or immunomodulators for the treatment of their *** after diagnosis of CID was seen in 7(77.8%)of exposed individuals vs 5(41.7%)individuals unexposed to biologics/immunomodulators(P=0.18).All 7 exposed compared to 3/5 unexposed developed a LS specific *** exposed and unexposed groups were followed for a median 10 years and 8.5 years,*** hazard ratio for cancer with medication exposure was 1.59(P=0.43,95%CI:0.5-5.1).CONCLUSION In patients with LS/HNPCC,the presence of a concurrent inflammatory condition,or use of immunosuppressive medication to treat the inflammatory condition,might not increase the rate of cancer occurrence in this limited study.
暂无评论